Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Paclitaxel, Oxaliplatin, Leucovorin and 5-Fluorouracil (POLF) in Gemcitabine-Refractory Advanced Pancreatic Cancer

NCT00323583 is registered in ClinicalTrials.gov with Seattle Cancer Treatment and Wellness Center as lead sponsor.

NCT NCT00323583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00323583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Paclitaxel, Oxaliplatin, Leucovorin and 5-Fluorouracil (POLF) in Gemcitabine-Refractory Advanced Pancreatic Cancer
Lead sponsor
Seattle Cancer Treatment and Wellness Center
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2006
Completion date
Not reported
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarincoma of pancreas, stage iii pancreatic cancer, stage iva pancreatic cancer, stage ivb pancreatic cancer